Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$5.86 CAD
Change Today -0.14 / -2.33%
Volume 7.4K
NRI On Other Exchanges
As of 3:36 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bradley S. Galer M.D.

Former President of Pain Group, Nuvo Research Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Bradley S. Galer, M.D. has been the Chief Medical Officer and Executive Vice President at Zogenix, Inc. since December 17, 2013. Dr. Galer served as the President of Pain Group at Nuvo Research Inc. from December 1, 2009 to December 13, 2013. Dr. Galer served as Vice President of Pain Products at Nuvo Research Inc. until December 1, 2009. He oversaw the strategy and operations of the Pain Group, including its commercialization, drug development activities, business ...

Read Full Background

Corporate Headquarters*

7560 Airport Road
Mississauga, Ontario L4T 4H4


Phone: 905-673-6980
Fax: 905-673-1842

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

Total Annual Compensation$346,250

Stock Options*

Exercisable Options114,375
Unexercisable Options375,575
Total Number of Options489,950

Total Compensation*

Total Annual Cash Compensation$491,250
Total Short Term Compensation$346,250
Total Calculated Compensation$588,282
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NRI:CN C$5.86 CAD -0.14


James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
Peter D. Staple Chief Executive Officer, President and Director
Corium International, Inc.
Robert S. Radie Chief Executive Officer, President and Director
Egalet Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUVO RESEARCH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at